Adia Med Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ADIA research report →
Price Chart
About the company
Adia Med Inc. is a publicly traded company dedicated to advancing regenerative medicine and healthcare innovation. The company operates through its primary divisions: Adia Med clinics and Adia Labs LLC.
- CEO
- Larry Powalisz
- IPO
- 2012
- Employees
- 3
- HQ
- Winter Park, FL, US
Get TickerSpark's AI analysis on ADIA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $13.97M
- P/E
- -0.11
- PEG
- -0.00
- P/S
- 21.12
- P/B
- -0.04
- EV/EBITDA
- -173.17
- Div Yield
- 0.00%
- Gross Margin
- 52.77%
- Op Margin
- -15.13%
- Net Margin
- -18.45%
- ROE
- 34.64%
- ROIC
- -16.30%
Latest fiscal year · YoY change
- Revenue
- $700.51K+0.0%
- Gross Profit
- $191.67K+0.0%
- Op Income
- $-366,492
- Net Income
- $-395,464+0.0%
- EPS
- $-4.23+0.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.28
- 52W Low
- $0.03
- 50D MA
- $0.13
- 200D MA
- $0.15
- Beta
- -8.23
- RSI (14)
- 56
- Avg Volume
- 14.59K
No earnings-call transcripts are available for ADIA yet.
- Free Float
- 91.8%
- Shares Outstanding
- 94.40M
- Float Shares
- 86.71M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 28, 11 | PivX Solutions, Inc. | buy | 10,000 |
| Dec 20, 11 | PivX Solutions, Inc. | buy | 16,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ADIA coverage
Recent articles, reports, and earnings notes.
No research on ADIA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ADIA report →Adia Med Partners with Live Oak Health (dba QCM Biologics) as Distributor and Sells 30% Stake in Adia Labs for $1.5 Million
newsfilecorp.com · Oct 6
Adia Med Inc. Announces Adia Labs Expansion of Regenerative Product Line
newsfilecorp.com · Sep 29
Adia Med Inc. Announces Adia Labs Biologic Inventory Now Exceeds $1.5 Million to Meet Rising Demand for the Company's Biological Products
newsfilecorp.com · Sep 22
Nasdaq Shareholder Requirements Just Verified By Adia Med
newsfilecorp.com · Sep 8
From Full Sail to Full-Scale: Adia Med Inc. Assembles Intern Social Media Team
newsfilecorp.com · Aug 31
Adia Med Inc. Engages Lucosky Brookman LLP as Legal Counsel for Planned NASDAQ Uplisting
newsfilecorp.com · Aug 24
Adia Med Delivers Record Q2 Results: $485K Revenue, First Net Profit, and Nearly Matches Full-Year 2025 Revenue in First Half
newsfilecorp.com · Aug 13
Adia Med Partners with Full Sail University; CEO Larry Powalisz to Present Company and Explore Student Assistance with SEO, Social Media, and Marketing
newsfilecorp.com · Aug 11
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.